TY  - JOUR
Y1  - 2024/04/28/
AV  - public
A1  - Sh. M. Mamasoliev, Sh. M. Mamasoliev
A1  - M.A. Artikova, M.A. Artikova
A1  - L. U. Zakirova, L. U. Zakirova
VL  - 2
SP  - 201
ID  - arxiv100834
EP  - 203
UR  - https://universalpublishings.com/index.php/itfttdm/article/view/5364
IS  - 4
N2  - The physiology of breathing during sleep predisposes to the onset or worsening of breathing disorders in patients with metabolic syndrome (MS), even if their respiratory function remains relatively normal while awake. Respiratory pathology often causes insomnia, which further aggravates the impairment of the quality of life of patients. Long-term low-flow oxygen therapy and noninvasive assisted ventilation improve gas exchange during sleep but often do not improve sleep disturbances (4, 3,5,7).
TI  - OBSTRUCTIVE SLEEP APNEA SYNDROME IN PATIENTS WITH METABOLIC SYNDROME
JF  - "XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TA?LIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR" nomli respublika ilmiy-amaliy konferensiyasi
KW  - insulin resistance (IR)
KW  -  Spearman (R)
KW  -  metabolic syndrome
KW  -  obstructive syndrome
KW  -  dysglycemia
ER  -